Search by Drug Name or NDC

    NDC 61269-0475-12 Xeloda 500 mg/1 Details

    Xeloda 500 mg/1

    Xeloda is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by H2-Pharma, LLC. The primary component is CAPECITABINE.

    Product Information

    NDC 61269-0475
    Product ID 61269-475_ece8fe89-a71f-45c3-a9b0-1349a5ac0c9d
    Associated GPIs
    GCN Sequence Number 039781
    GCN Sequence Number Description capecitabine TABLET 500 MG ORAL
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 31612
    HICL Sequence Number 018385
    HICL Sequence Number Description CAPECITABINE
    Brand/Generic Brand
    Proprietary Name Xeloda
    Proprietary Name Suffix n/a
    Non-Proprietary Name capecitabine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 500
    Active Ingredient Units mg/1
    Substance Name CAPECITABINE
    Labeler Name H2-Pharma, LLC
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020896
    Listing Certified Through 2024-12-31

    Package

    NDC 61269-0475-12 (61269047512)

    NDC Package Code 61269-475-12
    Billing NDC 61269047512
    Package 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61269-475-12)
    Marketing Start Date 1998-04-30
    NDC Exclude Flag N
    Pricing Information N/A